Michael Gapen, Morgan Stanley chief U.S. economist; Subadra Rajappa, Societe General head of U.S. rates strategy; and Jamie ...

Steve Liesman, JPMorgan’s David Kelly, Wolfe’s Stephanie Roth and Morgan Stanley’s Jim Caron, join 'Power Lunch' to discuss ...

Michael Grimes, a technology banker with Morgan Stanley , is in talks to leave the bank for a position in U.S. President ...

Morgan Stanley analyst Bob Huang notes that the Financial Times stated that Brighthouse Financial (BHF) is reportedly looking to sell itself ...

The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.

Intellia Therapeutics Inc (NTLA) stock saw a decline, ending the day at $10.01 which represents a decrease of $-0.54 or -5.12% from the prior close of $10.55. The stock opened at $10.64 and touched a ...

Morgan Stanley's proprietary sentiment indicator has gone into buy territory for the first time since mid-2022.  While it can ...

Morgan Stanley’s traders beat analysts’ estimates in the fourth quarter, joining their other Wall Street rivals in reporting ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

It's time to consider investing beyond U.S. equities and bonds, according to Morgan Stanley Wealth Management. Read more here ...

With Budget 2025 just around the corner, what should investors and businesses expect from the government’s fiscal roadmap? In this exclusive conversation, Upasana Chachra, India Chief Economist at ...

The stock market is expected to undergo a significant shift with potential recovery soon, as highlighted by Morgan Stanley.